Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: american-pharmacists-association.
fees reported
›
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
51 filings
$3.5M on those filings
Alcohol and Drug Abuse
ALC
30 filings
$993K on those filings
Budget/Appropriations
BUD
19 filings
$2.4M on those filings
Consumer Issues/Safety/Products
CSP
19 filings
$643K on those filings
Education
EDU
4 filings
$136K on those filings
Manufacturing
MAN
4 filings
$136K on those filings
Veterans
VET
3 filings
$602K on those filings
Environment/Superfund
ENV
2 filings
$404K on those filings
Defense
DEF
1 filing
$197K on those filings
Indian/Native American Affairs
IND
1 filing
$165K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
117th Congress
Mainstreaming Addiction Treatment Act of 2021
9 filingsthrough 2022
H.R. 592114th CongressPharmacy and Medically Underserved Areas Enhancement Act9 filingsthrough 2016
H.R. 793114th CongressEnsuring Seniors Access to Local Pharmacies Act of 20159 filingsthrough 2016
H.R. 2759117th CongressPharmacy and Medically Underserved Areas Enhancement Act8 filingsthrough 2022
H.R. 1034116th CongressPhair Pricing Act of 20198 filingsthrough 2020
H.R. 789116th CongressImproving Transparency and Accuracy in Medicare Part D Spending Act8 filingsthrough 2020
H.R. 803116th CongressImproving Transparency and Accuracy in Medicare Part D Spending Act8 filingsthrough 2020
H.R. 1038115th CongressImproving Transparency and Accuracy in Medicare Part D Spending Act8 filingsthrough 2018
H.R. 1245115th CongressAffordable and Safe Prescription Drug Importation Act8 filingsthrough 2018
H.R. 1316115th CongressPrescription Drug Price Transparency Act8 filingsthrough 2018
H.R. 1939115th CongressEnsuring Seniors Access to Local Pharmacies Act of 20178 filingsthrough 2018
H.R. 592115th CongressPharmacy and Medically Underserved Areas Enhancement Act8 filingsthrough 2018
S. 476116th CongressCreating Transparency to Have Drug Rebates Unlocked (C–THRU) Act of 20197 filingsthrough 2020
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Covered position:
16 filingsthrough 2013
Mark WellerDentons US LLP11 filingsthrough 2013
Alexander David LurieDentons US LLP11 filingsthrough 2013
Meredith Garrett IrvinDentons US LLP10 filingsthrough 2013
Kristina E LunnerAmerican Pharmacists Association9 filingsthrough 2010
Brian GallagherAmerican Pharmacists AssociationCovered position: Senior Vice President8 filingsthrough 2012
